Drugs: from discovery to approval
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Hoboken, NJ
Wiley-Liss
2004
|
| Schlagworte: | |
| Beschreibung: | XII, 355 S. Ill., graph. Darst. |
| ISBN: | 0471601500 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV019641066 | ||
| 003 | DE-604 | ||
| 005 | 20080425 | ||
| 007 | t | ||
| 008 | 041221s2004 ad|| |||| 00||| eng d | ||
| 020 | |a 0471601500 |9 0-471-60150-0 | ||
| 035 | |a (OCoLC)249544691 | ||
| 035 | |a (DE-599)BVBBV019641066 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-M382 |a DE-N2 | ||
| 082 | 0 | |a 615.1922 | |
| 084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
| 084 | |a VB 4010 |0 (DE-625)147021:253 |2 rvk | ||
| 084 | |a VS 5350 |0 (DE-625)147687:253 |2 rvk | ||
| 084 | |a 15,3 |2 ssgn | ||
| 100 | 1 | |a Ng, Rick |e Verfasser |0 (DE-588)139954066 |4 aut | |
| 245 | 1 | 0 | |a Drugs |b from discovery to approval |c Rick Ng |
| 264 | 1 | |a Hoboken, NJ |b Wiley-Liss |c 2004 | |
| 300 | |a XII, 355 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Arzneimitteldesign | |
| 650 | 4 | |a Arzneimittelentwicklung | |
| 650 | 4 | |a Arzneimittelprüfung | |
| 650 | 4 | |a Pharmazeutische Technologie | |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelprüfung |0 (DE-588)4128030-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Arzneimittelprüfung |0 (DE-588)4128030-1 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |D s |
| 689 | 3 | |5 DE-604 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-012969949 | ||
Datensatz im Suchindex
| _version_ | 1804133013006581760 |
|---|---|
| any_adam_object | |
| author | Ng, Rick |
| author_GND | (DE-588)139954066 |
| author_facet | Ng, Rick |
| author_role | aut |
| author_sort | Ng, Rick |
| author_variant | r n rn |
| building | Verbundindex |
| bvnumber | BV019641066 |
| classification_rvk | QR 525 VB 4010 VS 5350 |
| ctrlnum | (OCoLC)249544691 (DE-599)BVBBV019641066 |
| dewey-full | 615.1922 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.1922 |
| dewey-search | 615.1922 |
| dewey-sort | 3615.1922 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Wirtschaftswissenschaften Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01709nam a2200505 c 4500</leader><controlfield tag="001">BV019641066</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20080425 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">041221s2004 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0471601500</subfield><subfield code="9">0-471-60150-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)249544691</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV019641066</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-M382</subfield><subfield code="a">DE-N2</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.1922</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VB 4010</subfield><subfield code="0">(DE-625)147021:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5350</subfield><subfield code="0">(DE-625)147687:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ng, Rick</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)139954066</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drugs</subfield><subfield code="b">from discovery to approval</subfield><subfield code="c">Rick Ng</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, NJ</subfield><subfield code="b">Wiley-Liss</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XII, 355 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Arzneimitteldesign</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Arzneimittelentwicklung</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Arzneimittelprüfung</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmazeutische Technologie</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelprüfung</subfield><subfield code="0">(DE-588)4128030-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Arzneimittelprüfung</subfield><subfield code="0">(DE-588)4128030-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-012969949</subfield></datafield></record></collection> |
| id | DE-604.BV019641066 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T20:01:57Z |
| institution | BVB |
| isbn | 0471601500 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-012969949 |
| oclc_num | 249544691 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-M382 DE-N2 |
| owner_facet | DE-19 DE-BY-UBM DE-M382 DE-N2 |
| physical | XII, 355 S. Ill., graph. Darst. |
| publishDate | 2004 |
| publishDateSearch | 2004 |
| publishDateSort | 2004 |
| publisher | Wiley-Liss |
| record_format | marc |
| spelling | Ng, Rick Verfasser (DE-588)139954066 aut Drugs from discovery to approval Rick Ng Hoboken, NJ Wiley-Liss 2004 XII, 355 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Arzneimitteldesign Arzneimittelentwicklung Arzneimittelprüfung Pharmazeutische Technologie Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Pharmazeutische Technologie (DE-588)4045699-7 gnd rswk-swf Arzneimittelprüfung (DE-588)4128030-1 gnd rswk-swf Arzneimitteldesign (DE-588)4278218-1 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 s DE-604 Arzneimitteldesign (DE-588)4278218-1 s Arzneimittelprüfung (DE-588)4128030-1 s Pharmazeutische Technologie (DE-588)4045699-7 s |
| spellingShingle | Ng, Rick Drugs from discovery to approval Arzneimitteldesign Arzneimittelentwicklung Arzneimittelprüfung Pharmazeutische Technologie Arzneimittelentwicklung (DE-588)4143176-5 gnd Pharmazeutische Technologie (DE-588)4045699-7 gnd Arzneimittelprüfung (DE-588)4128030-1 gnd Arzneimitteldesign (DE-588)4278218-1 gnd |
| subject_GND | (DE-588)4143176-5 (DE-588)4045699-7 (DE-588)4128030-1 (DE-588)4278218-1 |
| title | Drugs from discovery to approval |
| title_auth | Drugs from discovery to approval |
| title_exact_search | Drugs from discovery to approval |
| title_full | Drugs from discovery to approval Rick Ng |
| title_fullStr | Drugs from discovery to approval Rick Ng |
| title_full_unstemmed | Drugs from discovery to approval Rick Ng |
| title_short | Drugs |
| title_sort | drugs from discovery to approval |
| title_sub | from discovery to approval |
| topic | Arzneimitteldesign Arzneimittelentwicklung Arzneimittelprüfung Pharmazeutische Technologie Arzneimittelentwicklung (DE-588)4143176-5 gnd Pharmazeutische Technologie (DE-588)4045699-7 gnd Arzneimittelprüfung (DE-588)4128030-1 gnd Arzneimitteldesign (DE-588)4278218-1 gnd |
| topic_facet | Arzneimitteldesign Arzneimittelentwicklung Arzneimittelprüfung Pharmazeutische Technologie |
| work_keys_str_mv | AT ngrick drugsfromdiscoverytoapproval |